cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Boston Scientific Corp
25 own
30 watching
Current Price
$47.59
$-0.5
(-1.04%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
68,154.01M
52-Week High
52-Week High
48.865
52-Week Low
52-Week Low
34.98
Average Volume
Average Volume
6.17M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
56.3277
iconMarket Capitalization68,154.01M
icon52-Week High48.865
icon52-Week Low34.98
iconAverage Volume6.17M
iconDividend Yield--
iconP/E Ratio56.3277
What does the Boston Scientific Corp do?
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; other coronary therapy products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral arterial disease; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors. In addition, the company offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; implantable cardiac resynchronization therapy pacemaker systems used to treat heart failure; and medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising steerable radio frequency ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Further, it provides products to diagnose and treat diseases of the pulmonary and gastrointestinal conditions; devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs; products to treat urinary stone disease and benign prostatic hyperplasia; mid-urethral sling products, sling and graft materials, pelvic floor reconstruction kits, and suturing devices; and spinal cord stimulator systems for the management of chronic pain. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Read More
How much money does Boston Scientific Corp make?
News & Events about Boston Scientific Corp.
Zolmax
1day ago
Boston Scientific Co. (NYSE:BSX Get Rating) EVP Arthur C. Butcher sold 27,000 shares of the businesss stock in a transaction dated Friday, February 3rd. The stock was sold at an average price of $48.74, for a total transaction of $1,315,980.00. Following the sale, the executive vice president now ...
PR Newswire
5days ago
BOSTON SCIENTIFIC INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Boston Scientific Corporation - BSX BOSTON SCIENTIFIC INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick...
Ticker Report
5days ago
Integrated Advisors Network LLC increased its position in shares of Boston Scientific Co. (NYSE:BSX Get Rating) by 35.2% in the 3rd quarter, according to its most recent disclosure with the Securities Exchange Commission. The institutional investor owned 8,437 shares of the medical ...
Boston Globe: Business
6days ago
A Michigan man says he was left with a $1,000 bill after his 6-year-old son ordered a virtual smorgasbord of food from several restaurants The post Michigan man says 6-year-old son ordered $1,000 in food from Grubhub appeared first on Boston.com...
PR Newswire
6days ago
Boston Scientific Receives FDA Clearance for LithoVue Elite Single-Use Digital Flexible Ureteroscope System Boston Scientific Receives FDA Clearance for LithoVue Elite Single-Use Digital Flexible Ureteroscope System PR Newswire MARLBOROUGH, Mass., Feb. 3, 2023 New technology designed to help inform...
Frequently Asked Questions
Frequently Asked Questions
What is Boston Scientific Corp share price today?
plus_minus_icon
Can Indians buy Boston Scientific Corp shares?
plus_minus_icon
How can I buy Boston Scientific Corp shares from India?
plus_minus_icon
Can Fractional shares of Boston Scientific Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Boston Scientific Corp stocks?
plus_minus_icon
What is today’s traded volume of Boston Scientific Corp?
plus_minus_icon
What is today’s market capitalisation of Boston Scientific Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Boston Scientific Corp?
plus_minus_icon
What percentage is Boston Scientific Corp down from its 52-Week High?
plus_minus_icon
What percentage is Boston Scientific Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$47.59
$-0.5
(-1.04%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Penumbra Inc
Penumbra Inc
$267.30
$0.20 (0.07 %)
Stryker Corporation
Stryker Corporation
$268.22
$-4.23 (-1.55 %)
Becton, Dickinson and Company
Becton, Dickinson and Company
$250.23
$-2.96 (-1.17 %)
Baxter International Inc.
Baxter International Inc.
$45.68
$0.07 (0.15 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Penumbra Inc
Penumbra Inc
$267.30
$0.20 (0.07 %)
Stryker Corporation
Stryker Corporation
$268.22
$-4.23 (-1.55 %)
Becton, Dickinson and Company
Becton, Dickinson and Company
$250.23
$-2.96 (-1.17 %)
Baxter International Inc.
Baxter International Inc.
$45.68
$0.07 (0.15 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00